Several devices have been designed and tried over the years to percutaneously close atrial septal defects (ASDs). Most of the devices were first experimented in animal models with subsequent clinical testing in human subjects. Some devices were discontinued or withdrawn from further clinical use for varied reasons and other devices received Food and Drug Administration (FDA) approval with consequent continued usage. The outcomes of both discontinued and currently used devices was presented in some detail. The results of device implantation are generally good when appropriate care and precautions are undertaken. At this time, Amplatzer Septal Occluder is most frequently utilized device for occlusion of secundum ASD around the world.
Keywords: Amplatzer Cribriform Device; Amplatzer Septal Occluder; Atrial Septal Defect Occluding System; Das Angel Wing Device; GORE® CARDIOFORM ASD Occluder; Gore HELEX® Device; King and Mill’s Device; Rashkind’s devices; atrial septal defect; buttoned device; clamshell occluder; outcome; percutaneous closure; transcatheter occlusion.